Back to Companies
Polaryx Therapeutics, Inc.
PLYXNasdaqCIK: 0002075320
Polaryx Therapeutics, Inc. (PLYX) shows 8 recent insider filings from 6 insiders, with all of them on the buy side. With $368.0K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $368.0K). Yang Alex Keun Mo (Chief Executive Officer, Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $360.0K by Yang Alex Keun Mo. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$368.0K
Purchases
$368.0K
Sales
$0
Unique Insiders
6
Recent Insider Trades
8 loaded
| May 28 | PLYX Polaryx Therapeutics, Inc. | Yang Alex Keun Mo | Chief Executive Officer, Director, 10% Owner | Buy | $360.0K |
| Feb 20 | PLYX Polaryx Therapeutics, Inc. | Landis G. Michael | Chief Financial Officer, Director | Buy | $8.0K |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Yang Alex Keun Mo | Chief Executive Officer, Director, 10% Owner | Other | $0 |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Landis G. Michael | Chief Financial Officer, Director | Other | $0 |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Braun III Francis A | Director | Other | $0 |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Bollinger Lisa | Chief Medical Officer | Other | $0 |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Ryan Charles S. | Director | Other | $0 |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | O Andrew John | Chief Investment Officer | Other | $0 |
8 filings